Home/Filings/4/0001104659-24-030175
4//SEC Filing

Kamocsay Jennifer 4

Accession 0001104659-24-030175

CIK 0001711933other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 9:53 PM ET

Size

9.3 KB

Accession

0001104659-24-030175

Insider Transaction Report

Form 4
Period: 2024-02-22
Kamocsay Jennifer
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2024-02-22+35,000102,500 total
  • Tax Payment

    Common Stock

    2024-03-01$6.03/sh3,283$19,79699,217 total
  • Award

    Employee Stock Option (Right to Buy)

    2024-02-22+70,00070,000 total
    Exercise: $5.35Exp: 2034-02-22Common Stock (70,000 underlying)
Footnotes (4)
  • [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on March 1, 2025, and annually thereafter until fully vested.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
  • [F3]Represents shares withheld to cover taxes on a restricted stock unit award previously granted February 23, 2023, which vest in four (4) equal annual installments beginning on March 1, 2024, and annually thereafter until fully vested.
  • [F4]The options shall vest as follows: twenty-five percent (25%) shall vest on February 22, 2025 with the remainder vesting in 36 equal monthly installments beginning on March 22, 2025.

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1
  • filerCIK 0001967264

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:53 PM ET
Size
9.3 KB